Arcturus Therapeutics Holdings Inc (ARCT)

Mar 26, 2025

(ARCT) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Mar 26, 2025

Mar 24, 2025

Bank of New York Mellon Corp Sells 22,024 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Mar 24, 2025

Mar 20, 2025

Is Arcturus Therapeutics (ARCT) a Worst High-Risk High-Reward Growth Stock to Buy? - Insider Monkey

Mar 20, 2025

Mar 20, 2025

Benign Growth For Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Underpins Stock's 26% Plummet - simplywall.st

Mar 20, 2025

Mar 18, 2025

Arcturus up 9% as phase 2 dosing begins for mRNA asset for cystic fibrosis - MSN

Mar 18, 2025

Mar 17, 2025

William Blair Issues Pessimistic Outlook for ARCT Earnings - Defense World

Mar 17, 2025

Mar 16, 2025

(ARCT) Proactive Strategies - news.stocktradersdaily.com

Mar 16, 2025

Mar 13, 2025

Arcturus Therapeutics Holdings Inc to Host Earnings Call - ACCESS Newswire

Mar 13, 2025

Mar 13, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives $61.40 Average PT from Analysts - Defense World

Mar 13, 2025

Mar 12, 2025

Arcturus Therapeutics at Leerink’s Conference: mRNA Innovations and Strategic Plans - Investing.com UK

Mar 12, 2025

Mar 12, 2025

Despite Revenue Setback, Arcturus Therapeutics (ARCT) Vaccine Breakthroughs Fuel Optimism - markets.businessinsider.com

Mar 12, 2025

Mar 11, 2025

Arcturus Therapeutics (NASDAQ:ARCT) Given New $68.00 Price Target at Canaccord Genuity Group - Defense World

Mar 11, 2025

Mar 09, 2025

Analysts Have Lowered Expectations For Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) After Its Latest Results - Simply Wall St

Mar 09, 2025

Mar 09, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance

Mar 09, 2025

Mar 09, 2025

HC Wainwright Lowers Arcturus Therapeutics (NASDAQ:ARCT) Price Target to $60.00 - Defense World

Mar 09, 2025

Mar 09, 2025

Arcturus Therapeutics (NASDAQ:ARCT) Earns Overweight Rating from Cantor Fitzgerald - Defense World

Mar 09, 2025

Mar 08, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 08, 2025

Mar 07, 2025

Arcturus Therapeutics stock hits 52-week low at $14.3 By Investing.com - Investing.com Australia

Mar 07, 2025

Mar 07, 2025

Beyond The Numbers: 8 Analysts Discuss Arcturus Therapeutics Stock - Benzinga

Mar 07, 2025

Mar 07, 2025

Arcturus Therapeutics stock hits 52-week low at $14.3 - Investing.com India

Mar 07, 2025

Mar 07, 2025

Earnings call transcript: Arcturus Therapeutics Q4 2024 misses estimates By Investing.com - Investing.com South Africa

Mar 07, 2025

Mar 07, 2025

Arcturus Therapeutics Reports Q4 2024 Earnings: EPS of ($1.11) M - GuruFocus.com

Mar 07, 2025

Mar 07, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q4 2024 Earnings Call - GuruFocus.com

Mar 07, 2025

Mar 07, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q4 2024 Earnings Call Highlights: Navigating ... - Yahoo Finance

Mar 07, 2025

Mar 07, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q4 2024 Earnings Call Highlights: Navigating ... By GuruFocus - Investing.com Canada

Mar 07, 2025

Mar 06, 2025

Arcturus Therapeutics Reports 2024 Financial Results and Pipeline Progress - TipRanks

Mar 06, 2025

Mar 06, 2025

Arcturus Therapeutics Holdings Inc earnings missed by $0.92, revenue fell short of estimates - Investing.com Canada

Mar 06, 2025

Mar 06, 2025

Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2024 Financial Update and Pipeline Progress - BioSpace

Mar 06, 2025

Mar 06, 2025

Earnings call transcript: Arcturus Therapeutics Q4 2024 misses estimates - Investing.com

Mar 06, 2025

Mar 06, 2025

Arcturus Therapeutics drops 7% as Q4 results disappoint - MSN

Mar 06, 2025

Mar 06, 2025

Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Mar 06, 2025

Mar 06, 2025

Arcturus Therapeutics Q4 and FY 2024 Financial Update - TradingView

Mar 06, 2025

Mar 05, 2025

Arcturus Therapeutics to Present at Leerink’s Global Healthcare Conference 2025 - BioSpace

Mar 05, 2025

Mar 05, 2025

Arcturus Therapeutics Q4 2024 Earnings Preview - MSN

Mar 05, 2025

Mar 05, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q4 2024 Earnings Repor - GuruFocus.com

Mar 05, 2025

Mar 05, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance

Mar 05, 2025

Mar 05, 2025

Synaptics Seeks to Alter the Trajectory of the IoT at Embedded World With Contextual Edge AI and Wireless Innovations - GlobeNewswire Inc.

Mar 05, 2025

Mar 05, 2025

mRNA Leader Arcturus Therapeutics Set for Key Investor Presentation at Leerink Conference - Stock Titan

Mar 05, 2025

Mar 01, 2025

ARK Investment Management LLC Reduces Stock Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - MarketBeat

Mar 01, 2025

Feb 28, 2025

Arcturus Therapeutics (ARCT) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Feb 28, 2025

Feb 27, 2025

Arcturus Therapeutics (ARCT) Projected to Post Earnings on Thursday - Defense World

Feb 27, 2025

Feb 24, 2025

Arcturus Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 6, 2025 - Business Wire

Feb 24, 2025

Feb 24, 2025

Can This mRNA Pioneer's Q4 Earnings Show Commercial Progress? March 6 Call Details - Stock Titan

Feb 24, 2025

Feb 23, 2025

Long Term Trading Analysis for (ARCT) - news.stocktradersdaily.com

Feb 23, 2025

Feb 20, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Short Interest Down 9.9% in January - MarketBeat

Feb 20, 2025

Feb 19, 2025

Empire Life Investments Inc. Purchases 128,771 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - MarketBeat

Feb 19, 2025

Feb 18, 2025

HC Wainwright Reaffirms Buy Rating for Arcturus Therapeutics (NASDAQ:ARCT) - MarketBeat

Feb 18, 2025